A calcium channel sensitizer approved for use in treatment of Congestive Hea failure is-
Correct Answer: Levosimendan
Description: levosimendan is a calcium channel channel sensitiser used in CHF Levosimendan is a calcium sensitiser that can be administered intravenously (IV) to patients with acute decompensated congestive hea failure (CHF). At therapeutic dosages levosimendan enhances myocardial contractility without increasing oxygen requirements, and causes coronary and systemic vasodilation. Ref Davidson edition23rd pg 463
Category:
Medicine
Get More
Subject Mock Tests
Practice with over 200,000 questions from various medical subjects and improve your knowledge.
Attempt a mock test nowMock Exam
Take an exam with 100 random questions selected from all subjects to test your knowledge.
Coming SoonGet More
Subject Mock Tests
Try practicing mock tests with over 200,000 questions from various medical subjects.
Attempt a mock test now